APYX (Apyx Medical) Dividend-Payout-to-FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APYX Apyx Medical Corp APYX
72 GF Score
Price $3.11
GF Value $2.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Apyx Medical Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.

APYX
72GF Score
Apyx Medical Corp APYX
Dividend-Payout-to-FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Apyx Medical (APYX) Overvalued in 2026?

Based on GuruFocus' analysis, Apyx Medical stock appears to be overvalued. The current stock price of $3.11 is trading 40.7% above its estimated GF Value™ of $2.21. GuruFocus considers Apyx Medical to be Significantly Overvalued.

Key valuation signals for APYX:

  • Dividend-Payout-to-FFO:
  • GF Value™: $2.21 vs. price of $3.11 (40.7% above fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the APYX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apyx Medical Business Description

Other Exchanges BOV:Germany
Address 5115 Ulmerton Road, Clearwater, FL, USA, 33760
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
72GF Score

Get the complete analysis for APYX

Dividend-Payout-to-FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.11
Price
$2.21
GF Value